|
|
Article: Schering-Plough chief stands by Vytorin.(TOP STORIES)(Brief article)
- Article from:
- MondayMorning
- Article date:
- January 21, 2008
CopyrightCOPYRIGHT 2008 MedContent Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Schering-Plough Chief Stands by Vytorin. Schering-Plough Corp. (Kenilworth NJ) Chief Executive Fred Hassan says the company stands by the effectiveness of its cholesterol drug Vytorin after a study showed it may work no better than an older, less expensive medicine. Doctors and investors said the data on Vytorin, released last week, may hurt sales of the drug. It is "very early to make too many judgments and decisions because the data isn't all out yet," Hassan said, adding he was surprised by the reaction. Schering fell 23% for the week to $21.28 after the company released data showing Vytorin reduced artery-clogging plaque no better than a generic form of Zocor. Vytorin ...
Related newspaper, magazine, and journal articles:
|
|
Article: Fed: Police chief stands by drug case cooperation
AAP General News (Australia);
October 26, 2005 ;
531 words
...AAP General News (Australia) 10-26-2005 Fed: Police chief stands by drug case cooperation CANBERRA, Oct 26 AAP - Australian Federal Police chief Mick Keelty will not apologise for sharing intelligence ...
|
|